共 280 条
- [1] McCrindle BW(2017)Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association Circulation 135 e927-e999
- [2] Rowley AH(2019)Refractory Kawasaki disease: diagnostic and management challenges Pediatric Health Med Ther 10 131-139
- [3] Newburger JW(2020)Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease Curr Opin Pharmacol 54 72-81
- [4] Burns JC(2021)Predictive value of the systemic immune-inflammation index for intravenous immunoglobulin resistance and cardiovascular complications in Kawasaki disease Front Cardiovasc Med 8 711007-227
- [5] Bolger AF(2021)Increased pentraxin 3 levels correlate with IVIG responsiveness and coronary artery aneurysm formation in Kawasaki disease Front Immunol 12 624802-274
- [6] Gewitz M(2020)Do cytokines correlate with refractory Kawasaki disease in children? Clin Chim Acta 506 222-1850
- [7] Baker AL(2020)Kawasaki disease and COVID-19 Mediterr J Rheumatol 31 268-834
- [8] Jackson MA(2022)Cytokine profiles as potential prognostic and therapeutic markers in SARS-CoV-2-induced ARDS J Clin Med 11 2951-2106
- [9] Takahashi M(2006)Non-invasive assessment of endothelial function: which technique? J Am Coll Cardiol 48 1846-1115
- [10] Shah PB(2010)From endothelial dysfunction to atherosclerosis Autoimmun Rev 9 830-111